Bienvenue sur le nouveau Boursorama. Découvrez tout ce qui a changé
  1. Aide
    1. Espace client
    2. Connexion
Accès membre Boursorama

Erreur d'authentification

Vous êtes authentifié. Nous chargeons votre espace membre.

Mot de passe oublié ?

Nouveau sur Boursorama ? Devenez membre

Identifiant/Mot de passe oublié
Si vous êtes Membre de la Communauté Boursorama, veuillez indiquer l'adresse email que vous avez fournie lors de votre enregistrement pour recevoir votre identifiant et/ou ré-initialiser votre mot de passe :

Nouveau sur Boursorama ? Devenez membre




Ouverture théorique 457.00
indice de référence SBF 120

FR0000038259 ERF

Euronext Paris données temps réel
Politique d'exécution
  • ouverture


  • clôture veille


  • + haut


  • + bas


  • volume

    28 817

  • valorisation

    8 044 MEUR

  • capital échangé


  • dernier échange

    23.03.18 / 17:35:28

  • limite à la baisse

    Qu'est-ce qu'une limite à la hausse/baisse ?



  • limite à la hausse

    Qu'est-ce qu'une limite à la hausse/baisse ?



  • Éligibilité


    Qu'est-ce que le SRD ?


    Qu'est-ce que le PEA ?


Autres places de cotation

  • + Alerte

  • + Portefeuille

    Ajouter EUROFINS SCIENTIF à un portefeuille virtuel

  • + Liste

    Ajouter EUROFINS SCIENTIF à mes listes


EUROFINS SCIENTIFIC : New CAP accreditation in China adds to Eurofins’ market-leading offerings on International Accreditation Day

Actusnews09/06/2009 à 12:00

Brussels, June 9, 2009

Eurofins today celebrates the second ILAC International Accreditation Day, a global initiative jointly established by the International Accreditation Forum (IAF) and International Laboratory Accreditation Cooperation (ILAC) to raise awareness of the importance of accreditation-related activities.

Standards and accreditation play an increasingly important role in promoting global growth and trade. Many factors have contributed to this: Mass production, globalization, concerns about litigation, demand for cheaper goods and finally the increasing public demand for product safety and concerns about technical compatibility between products. Furthermore many Government regulators have to rely on third-party organisations to support their regulatory efforts. When they do so, they need a fair and meaningful basis for identifying qualified and competent providers. Accreditation provides this declaration of competence.

The Eurofins Group is therefore proud to announce the recent award of the College of American Pathologists (CAP) accreditation to its new central laboratory in China. With this accreditation, Eurofins' position as one of the few providers of a wholly-owned global network of central laboratories is even more firmly established, covering the world's key regions of pharmaceutical development: North America, Europe and Asia, with two laboratories in each. In addition to the laboratory quality assurance standards of CAP, the standards in this laboratory in China meet a wide range of pharmaceutical industry regulatory requirements such as the National Glycohaemoglobin Standardization Program (NGSP) Level 1 certification. The facility provides a full range of safety parameters and has extended its offering by adding a range of HPLC and ELISA-based testing.

With over 500 accreditations, approvals and certified standards in its various laboratories around the world, Eurofins is probably the laboratory organisation with the widest scope in that respect operating in the world today. The Group has built a position as a global market leader in three main markets of bioanalytical laboratory testing: food & feed testing (where it holds the clear number one position worldwide), pharmaceutical services (a top 10 service provider) and environmental testing (number one in Europe). Eurofins firmly believes that the accreditations gained as a result of its hard work, integrity and expertise allow it to give customers total trust in their testing results.

In addition to providing standards of excellence in its long-established laboratories, Eurofins' mission is to bring these accreditations to emerging markets and regions, providing support to authorities who wish to implement internationally recognised standards in local markets as well as reassurance to multinational operators who increasingly source goods and services in these developing areas. On top of the CAP accreditation in China, the Group has opened and received CAP accreditation at its central lab in Singapore as well as achieving the DACH accreditation gained in May for its Chinese food testing laboratory at Suzhou, just outside Shanghai. Eurofins is also the only GMO-testing laboratory that is ISO 17025 accredited in South America.

As an example the Eurofins Group is able to offer the following widely-recognised accreditations and standards around the world: UKAS, GS DANAK, FDA, ILAC-MRA, DAR, OFTA, IECEE, ICE, Swiss Testing, KBA, CTIA, EMSD, FCC, NSAI, COFRAC, PTCRB, Bluetooth and E1. There are many others available. In addition many of its laboratories have also obtained the OECD GLP, GMP and GCP standards as well as conforming to ISO 17025. In the face of increasing uncertainties concerning human safety, Eurofins welcomes this ILAC initiative to support its investment in providing the highest quality of analytical testing services throughout its worldwide laboratory network.

For further information please contact Eurofins at :

Stuart Morgan or Florian Heupel

Phone:    +32-2-766 1620


Notes for the editor:

Eurofins - a global leader in bio-analysis

Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors.

With 8,000 staff in more than 150 laboratories across 30 countries, Eurofins offers a portfolio of over 25,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to providing its customers with high quality services, accurate results in time and, if requested, expert advice by its highly qualified staff.

The Eurofins Group is the world leader in food testing and one of the global market leaders in pharmaceuticals and environmental testing. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris (ISIN FR0000038259) and Frankfurt (WKN 910 251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERF FP, ESF, EUFI.DE).

About ILAC

The International Laboratory Accreditation Cooperation (ILAC) first started as a conference in 1977 with the aim of developing international cooperation for facilitating trade by promotion of the acceptance of accredited test and calibration results. In 1996, ILAC became a formal cooperation with a charter to establish a network of mutual recognition agreements among accreditation bodies that would fulfil this aim. The ILAC Arrangement is the culmination of 22 years of intensive work.

On 2 November 2000, 36 laboratory accreditation bodies, full members of the International Laboratory Accreditation Cooperation (ILAC), from 28 economies worldwide signed an 'arrangement' in Washington, DC to promote the acceptance of technical test and calibration data for exported goods.

The arrangement came into effect on 31 January 2001. The 'ILAC Arrangement' provides significant technical underpinning to international trade. The key to the Arrangement is the developing global network of accredited testing and calibration laboratories that are assessed and recognised as being competent by ILAC Arrangement signatory accreditation bodies.

The signatories have, in turn, been peer-reviewed and shown to meet ILAC's criteria for competence. Now that the ILAC Arrangement is in place, governments can take advantage of it to further develop or enhance trade agreements. The ultimate aim is increased use and acceptance by industry as well as government of the results from accredited laboratories, including results from laboratories in other countries. In this way, the free-trade goal of 'product tested once and accepted everywhere' can be realised.

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Activité de l'émetteur (acquisitions, cessions...) Communiqué intégral et original au format PDF :
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free


Valeurs associées

Mes listes




0.708 -3.54%
0.941 +1.29%
0.219 +40.79%
0.407 +5.99%
1.41 +0.50%

Les Risques en Bourse


Note d'information importante

Chère Cliente, Cher Client,

Nous souhaitons vous donner quelques règles à suivre pour investir dans les meilleures conditions et vous présenter les risques potentiels auxquels vous êtes susceptibles d'être exposés.

Vos connaissances, Votre profil d'investisseur
Tout d'abord évaluez vos connaissances boursières et financières et formez-vous en consultant le Guide de l'Investisseur, véritable introduction à la bourse et à l'épargne qui est disponible sur votre site Boursorama Banque sous la rubrique «Aide/Formation».
Définissez ensuite votre profil d'investisseur (prudent, équilibré, dynamique) et vos objectifs (durée de placement, rentabilité …). Ce constat vous permettra de vous orienter vers les produits et les marchés qui vous sont le mieux adaptés.

Pensez à vos besoins de liquidité
Adaptez votre durée de placement (1 mois, 1 an, 5 ans, …) à vos besoins de liquidités (projets, impôts …) et en tout état de cause, n'investissez pas en Bourse une partie trop importante de votre patrimoine.

La composition de votre portefeuille
Etudiez la composition de votre portefeuille : diversifiez vos placements afin de réduire au maximum le risque inhérent à un support ou à un secteur en particulier et n'investissez pas dans les produits optionnels (warrants, certificats), fortement risqués, si votre portefeuille n'est pas suffisamment important.

Connaître la vie des Sociétés
Renseignez-vous sur la société au sein de laquelle vous envisagez d'investir (actualités, santé financière, opérations à venir, …).

Agir en connaissance de cause
Soyez conscient des risques auxquels vous êtes exposés : de fait, si certains produits (actions volatiles, warrants, certificats, future…) ou certains modes d'investissement (Service de Règlement Différé) augmentent les espérances de gain, ils accroissent aussi fortement le risque de perte (totale). Ainsi, une connaissance technique préalable approfondie est requise, c'est pourquoi nous conseillons aux néophytes de s'écarter de ce type de produits.

Des risques différents selon les marchés
Prenez connaissance des caractéristiques des marchés sur lesquels vous allez investir : vous êtes confrontés à un risque variable (liquidité, volatilité, niveau d'information, change…) selon les marchés sur lesquels vous décidez d'intervenir (Premier Marché, Second Marché, Nouveau marché, Marché Libre, Marché étranger…).

Figez vos pertes
Enfin, la règle d'or à retenir est de savoir figer ses pertes : à vous de définir le montant de perte acceptable dès le début et une fois ce niveau atteint agissez en conséquence.

En appliquant ces quelques règles de bonnes conduite vous serez à même de mieux appréhender votre risque lorsque vous allez investir sur les Marchés

Un ensemble de cours complets sur la Bourse est également mis à votre disposition gratuitement et que vous pouvez retrouver sur votre site Boursorama Banque dans la rubrique «Aide/Formation». Si des questions resteraient en suspend, n'hésitez pas à contacter votre agence qui est à votre disposition.

L'équipe de Boursorama Banque.